In 2019, the Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS/JHRS 2019)
were published, covering areas such as treatment using cardiac electrical implantable …

Multiple clinical practice guidelines (CPGs) for heart failure management have been
published to provide the best practices regarding the use of foundational therapies to reduce …

Mechanical circulatory support (MCS) plays a significant role as a therapeutic option for
severe heart failure, and its outcomes have been improving due to advancements in devices …

Background: Recently, destination therapy (DT) was approved in Japan, and patients
ineligible for heart transplantation may now receive durable left ventricular assist devices …

Background Adequate self-care behaviour is essential for patients with a left ventricular
assist device (LVAD) to prevent complications, prolong life, and optimise quality of life …

Cardiomyopathy is a pathological condition characterized by cardiac pump failure due to
myocardial dysfunction and the major cause of advanced heart failure requiring heart …

Objective To evaluate the real-world safety and effectiveness of inhaled nitric oxide (INOflo®
for Inhalation 800 ppm) for perioperative pulmonary hypertension associated with cardiac …

The comparative severity of patent foramen ovale (PFO)-related stroke in patients without
atrial fibrillation (AF) and AF-related stroke in patients without PFO is unknown. Therefore …

Background Mechanical assist device indications have changed in recent years. Reduced
incidence of complications, better survival, and the third generation of mechanical support …

Diabetes is a major public health concern and is increasing worldwide. Generally, diabetes
plays a role in the development and progression of heart failure, contributing to an increased …